Common genetic variations in telomere length genes and lung cancer
Ricardo Cortez Cardoso PenhaiD, Karl Smith‐ByrneiD, Joshua Ronald AtkinsiD, Philip HaycockiD, Siddhartha KariD, Veryan CoddiD, Nilesh J. SamaniiD, Christopher P. NelsoniD, Maja MilojeviciD, Aurélie AG GabrieliD, Christopher Ian AmosiD, Paul BrennaniD, Rayjean J Hung, Linda KachuriiD, James McKayiD
Abstract
BackgroundGenome-wide association studies (GWAS) have identified genetic susceptibility variants for both leukocyte telomere length (LTL) and lung cancer susceptibility. Recently, 108 novel genetic loci within genes involved in telomere biology and DNA repair have been linked to LTL in UK Biobank. In the current work, we investigated the relationship between genetically predicted LTL and lung cancer. MethodsTo explore the shared genetic basis between LTL and lung cancer, we performed genetic correlation, Mendelian Randomization (MR), and colocalisation analyses using the largest available GWASs of LTL (N=464,716) and lung cancer (29,239 cases; 56,450 controls). To further characterize the molecular mechanisms underlying this relationship, principal component analysis (PCA) was used to summarize gene expression profiles in lung adenocarcinoma tumours from The Cancer Genome Atlas. ResultsAlthough there was no genome-wide genetic correlation between LTL and lung cancer risk (rg=-0.01, p=0.88), MR analyses using 144 instruments identified a putatively causal association. Longer LTL conferred an increased risk of lung cancer (OR=1.62, 95%CI=1.44-1.83, p=9.9x10-15), lung cancer in never smokers (OR=2.02, 95%CI=1.45-2.83, p=3.78x10-05), and lung adenocarcinoma (OR=2.43, 95%CI=2.02-2.92, p=3.8x10-21). Of these 144 LTL genetic instruments, 12 showed evidence of colocalisation with lung adenocarcinoma risk and revealed novel susceptibility loci, including MPHOSPH6 (rs2303262), PRPF6 (rs80150989), and POLI (rs2276182). A polygenic risk score for LTL was associated with the second principal component (PC2) of gene expression (Beta=0.17, p=1.0x10-3). The aspect of PC2 associated with longer LTL was also associated with being female (p=0.005), never smokers (p=0.04), and earlier tumour stage (p=0.002). PC2 was strongly associated with cell proliferation score (p=3.6x10-30) and genomic features related to genome stability, including copy number changes (p=1.6x10-5) and telomerase activity (p=1.3x10-5) in the multivariate regression analyses. ConclusionsThis study identified an association between longer genetically predicted LTL and lung cancer and sheds light on the potential molecular mechanisms related to LTL in lung adenocarcinomas.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genetic analysis of lung cancer reveals novel susceptibility loci and germline impact on somatic mutation burden
Aurélie AG Gabriel, Joshua Ronald Atkins, … James McKay·JNCI Journal of the National Cancer InstitutePeer-reviewed·Apr 27, 2022
- Multi-ancestry meta-analyses of lung cancer in the Million Veteran Program reveal novel risk loci and elucidate smoking-independent genetic risk
Bryan R. Gorman, Sun‐Gou Ji, … Saiju Pyarajan·Nature CommunicationsPeer-reviewed·Oct 4, 2024
- IL-18 and Lower Risk for Lung Cancer: Triangulated Evidence from Germline Predictions, Pre-Diagnostic Measurements, and Tumor Expression
Karl Smith-Byrne, Yan Chen, … Anders Mälarstig·medRxiv·Mar 26, 2021
- Genetic architecture of lipoma susceptibility implicates telomere biology
David Bryant Lowry·medRxiv·Sep 9, 2026
- Large-scale association study identifies lung cancer susceptibility copy number variants and their potential functional role in genetic instability
Feifei Xiao, Fei Qin, … Christopher Ian Amos·Cancer Epidemiology Biomarkers & PreventionPeer-reviewed·Oct 19, 2026
- Inherited rare, deleterious variants in ATM increase lung adenocarcinoma risk
Myvizhi Esai Selvan, Marjorie Glass Zauderer, … Zeynep Hulya Gumus·Journal of Thoracic OncologyPeer-reviewed·Aug 28, 2020